retatrutide parkinson's disease trial nct produces up to 30.3% weight loss in Phase 3 Abstracts Presented at the 32nd

The news: Eli Lilly is launching Lilly Employer Connect, a direct-to-employer platform for its obesity drug Zepbound, offering flat pricing for companies

The plaintiff alleges that Ozempic led to her diagnosis of non-arteritic anterior ischemic optic neuropathy (NAION), a rare and serious condition involving loss of blood flow to the optic nerve

Mounjaro is the diabetes-approved version of tirzepatide

You will throw up

Low-grade chronic inflammation is now known to be a major contributor to a myriad of conditions, including cancer, obesity and diabetes (Underwerth)

Though the USDA does not regulate humane labeling, you may see labeling by independent organizations such as Human Farm Animal Care or Animal Welfare Approved